Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation

Molecular Endocrinology

Volumn 13, Issue 6, 1999, Pages 969-980

  Lazennec, Gwendal ^a,d   Alcorn, Joseph L ^c   Katzenellenbogen, Benita S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADENOVIRUS; ARTICLE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL PROLIFERATION; EMBRYO; ESTROGEN RELEASE; FLOW CYTOMETRY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

EID: 0033304653     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.6.0318     Document Type: Article

References (24)

1. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
2. Characterization and regulation of estrogen and progesterone receptors in breast cancer
3. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
4. Antiestrogens: Mechanisms of action and resistance in breast cancer
5. Endocrine treatment of breast cancer in women
6. Antiestrogen resistance: Mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy
7. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer
8. Powerful dominant negative mutants of the human estrogen receptor
9. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors
10. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness
11. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
12. Characteristics of a human cell line transformed by DNA from adenovirus type 5
13. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5
14. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7
15. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells
16. Molecular basis of agonism and antagonism in the oestrogen receptor
17. 1 phase of the cell cycle
18. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells
19. Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy
20. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2
21. Effects of a recombinant adenovirus expressing WAF1/Cipl on cell growth, cell cycle, and apoptosis
22. Bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice
23. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination